Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 20, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Standard Biotools Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Api Group Corp
| -3.04M |
$34.25 | -$104,072,632.25 | -60.89% | 1.95M |
Mar 5
| |||||||
Api Group Corp
| -3.04M |
$34.25 | -$104,072,632.25 | -60.89% | 1.95M |
Mar 5
| |||||||
Api Group Corp
| 4.14M |
$30.75 | $51,741,659.70 | +41.73% | 14.05M |
Feb 28
| |||||||
Api Group Corp
| 4.14M |
$30.75 | $51,741,659.70 | +41.73% | 14.05M |
Feb 28
| |||||||
Rayzebio, Inc.
| -6.64M |
—
|
—
| -100.00% |
0
|
Feb 26
| |||||||
Rayzebio, Inc.
| -6.64M |
—
|
—
| -100.00% |
0
|
Feb 26
| |||||||
4d Molecular Therapeutics, Inc.
| -540.00K |
$19.53 | -$10,546,200.00 | -11.28% | 4.25M |
Jan 4
| |||||||
Api Group Corp
| -6.50M |
$31.30 | -$203,450,000.00 | -18.90% | 27.89M |
Jan 2
| |||||||
Api Group Corp
| -6.50M |
$31.30 | -$203,450,000.00 | -18.90% | 27.89M |
Jan 2
| |||||||
Rayzebio, Inc.
| 6.64M |
$18.00 |
—
|
∞
| 6.64M |
Sep 19
| |||||||
Rayzebio, Inc.
| 6.64M |
$18.00 |
—
|
∞
| 6.64M |
Sep 19
| |||||||
Rayzebio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Rayzebio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Inhibrx, Inc.
| 511.63K |
$19.35 | $9,899,982.45 |
∞
| 511.63K |
Aug 28
| |||||||
Bridgebio Pharma, Inc.
| -1.50M |
$35.00 | -$52,500,000.00 | -5.63% | 25.12M |
Jul 18
| |||||||
Roivant Sciences Ltd.
| -13.00M |
$9.90 | -$128,700,000.00 | -14.73% | 75.24M |
Jun 22
| |||||||
Roivant Sciences Ltd.
| -13.00M |
$9.90 | -$128,700,000.00 | -14.73% | 75.24M |
Jun 22
| |||||||
4d Molecular Therapeutics, Inc.
| 850K |
$16.00 | $13,600,000.00 | +21.59% | 4.79M |
May 9
| |||||||
Frazier Lifesciences Acquisition Corp
| -3.67M |
—
|
—
| -100.00% |
0
|
Nov 22
| |||||||
Rallybio Corp
|
0
|
—
|
—
|
—
|
0
|
Nov 15
| |||||||
Frazier Lifesciences Acquisition Corp
| 847.06K |
$10.08 | $8,538,384.96 | +29.99% | 3.67M |
Nov 2
| |||||||
Frazier Lifesciences Acquisition Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Inhibrx, Inc.
| 1.33M |
$30.00 | $39,999,856.67 | +93.42% | 2.76M |
Oct 7
| |||||||
Amylyx Pharmaceuticals, Inc.
| -1.40M |
$29.80 | -$41,719,639.31 | -10.26% | 12.24M |
Sep 8 - Sep 9
| |||||||
Procept Biorobotics Corp
| -1.25M |
$29.90 | -$37,345,100.00 | -25.45% | 3.66M |
Mar 18
| |||||||
Ginkgo Bioworks Holdings, Inc.
| -288.00M |
—
|
—
| -84.94% | 51.06M |
Mar 2
| |||||||
Amylyx Pharmaceuticals, Inc.
| 7.17M |
$19.00 | $43,700,000.00 |
∞
| 7.17M |
Jan 11 - Nov 11
| |||||||
Amylyx Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Api Group Corp
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Roivant Sciences Ltd.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Roivant Sciences Ltd.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ginkgo Bioworks Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Procept Biorobotics Corp
| 4.6M |
$35.00 | $14,000,000.00 | +1,492.74% | 4.91M |
Sep 17
| |||||||
Procept Biorobotics Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Figs, Inc.
| -200.00K |
$46.78 | -$9,355,905.32 | -1.34% | 14.74M |
Sep 2 - Sep 3
| |||||||
Rallybio Corp
| 4.19M |
$13.00 |
—
|
∞
| 4.19M |
Jul 29
| |||||||
Rallybio Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Figs, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
4d Molecular Therapeutics Inc.
| 3.94M |
$23.00 |
—
|
∞
| 3.94M |
Dec 15
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.